Literature DB >> 2537684

2',3'-cyclic nucleotide 3'-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system.

T J Sprinkle1.   

Abstract

2',3'-Cyclic nucleotide 3'-phosphohydrolase (E.C. 3.1.4.37; CNPase) is a myelin-associated enzyme. In central and peripheral nervous system tissues, the enzyme is localized almost exclusively in the two cell types that elaborate myelin, the oligodendrocyte and the Schwann cell, respectively. Nonneural sources of CNPase have also been described, but they all have much lower activities than those found in brain. The freshly isolated brain enzymes appear as closely spaced doublets at approximately 46 and 48 kDa on SDS-PAGE. The primary sequence appears highly conserved between these two proteins, designated CNP1 and CNP2. Major structural differences between these two proteins are most likely due to posttranslational modifications of the enzyme itself (certainly phosphorylation, possibly others) or to alternative splicing. The primary sequences of rat and bovine brain CNPase have now been deduced from the cDNA sequences and the enzymes appear to be unique. Current research suggests that CNPase is involved in the very rapid growth of myelin membrane during early oligodendrocyte membrane biogenesis and possibly maintenance. The absolute hydrolysis specificity, yielding 2'-mononucleotides from 2',3'-cyclic substrates, strongly suggests that CNPase is a nucleic acid enzyme, possibly related to RNA metabolism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537684

Source DB:  PubMed          Journal:  Crit Rev Neurobiol        ISSN: 0892-0915


  70 in total

1.  Characterization of the Saccharomyces cerevisiae cyclic nucleotide phosphodiesterase involved in the metabolism of ADP-ribose 1",2"-cyclic phosphate.

Authors:  F Nasr; W Filipowicz
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

2.  Structure and mechanism of activity of the cyclic phosphodiesterase of Appr>p, a product of the tRNA splicing reaction.

Authors:  A Hofmann; A Zdanov; P Genschik; S Ruvinov; W Filipowicz; A Wlodawer
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

3.  disabled-1 functions cell autonomously during radial migration and cortical layering of pyramidal neurons.

Authors:  V Hammond; B Howell; L Godinho; S S Tan
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

4.  2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors.

Authors:  Edwin K Jackson; Delbert G Gillespie; Raghvendra K Dubey
Journal:  J Pharmacol Exp Ther       Date:  2011-01-26       Impact factor: 4.030

Review 5.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

6.  Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy.

Authors:  Laurence Meyer; Christine Patte-Mensah; Omar Taleb; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Life Sci       Date:  2010-04-30       Impact factor: 9.261

7.  Continuation of neurogenesis in the hippocampus of the adult macaque monkey.

Authors:  D R Kornack; P Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

8.  Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  Free Radic Biol Med       Date:  2005-09-15       Impact factor: 7.376

9.  Binge-like postnatal alcohol exposure triggers cortical gliogenesis in adolescent rats.

Authors:  Jennifer L Helfer; Lyngine H Calizo; Willie K Dong; Charles R Goodlett; William T Greenough; Anna Y Klintsova
Journal:  J Comp Neurol       Date:  2009-05-20       Impact factor: 3.215

10.  Glial expression of the proenkephalin gene in slice cultures of the subventricular zone.

Authors:  L Just; C Olenik; D K Meyer
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.